 |
MELBOURNE, Australia, April 11, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces the Chinese National Medical Products Administration (NMPA) Center for Drug Evaluation (CDE) has approved a Phase I study of TLX101 investigational therapy (4-L-[131I] iodo-phenylalanine, or 131I-IPA) in Chinese...
Read more: Chinese NMPA Approves Study of Telix Brain Cancer Therapy Candidate
Hashtag.net.au
Severe tooth loss can affect far more than appearance. It can impact chewing ability, speech, facial structure, and overall confidence. For individuals missing most or all of their teeth, All on 4 D...
Hashtag.net.au
For many people, dental anxiety isn’t just a minor worry — it’s a barrier that keeps them from getting the care they need. The sound of drills, the sterile scent, or even a simple check-up can cause h...
Hashtag.net.au
Getting a restful night's sleep is essential for overall health and well-being. For many, external noises—be it a snoring partner, traffic, or noisy neighbors—can disrupt sleep patterns. One effective...